To evaluate muscle injury using magnetic resonance imaging after an intragluteal injection of Diclofenac sodium 75 mg/1mL

A prospective open label single arm single centre case study of MRI of Dynapar AQ 75 mg/ml IM

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/01/023010

Enrollment

Registered

2020-01-28

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Dynapar AQ: Diclofenac Sodium 75 mg per 1 ml will be injected for one time only by Intragluteal route Control Intervention1: NIL: NIL

Eligibility

Inclusion criteria

Inclusion criteria: Male above 18 years of age

Exclusion criteria

Exclusion criteria: Contraindications of diclofenac injection

Design outcomes

Primary

Measure	Time frame
to evaluate muscle injury using MRI following a diclofenac 75 mg/1ml intragluteal injectionTimepoint: Magnetic Resonance Imaging will be done at 2, 12, 22, 32, 47, 62, 92, 122, 182, 242 min, as well 7.5 hr after administration	—

Secondary

Measure	Time frame
to observe any change in the inflammatory biomarkers following a diclofenac 75 mg/1ml intragluteal injectionTimepoint: Magnetic Resonance Imaging will be done at 2, 12, 22, 32, 47, 62, 92, 122, 182, 242 min, as well 7.5 hr after administration	—

Countries

India

Contacts

Public ContactDr Dushyant Balat

Apollo Hospitals International Ltd

drdushyant.balat@gmail.com9825015055

Outcome results